Nanotechnology in Medicine: From Molecules to Humans

本次ECI医学纳米技术会议的中心目标是提供一个平台， 该领域研究人员之间的全球讨论，其总体目标是帮助 了解纳米技术诱导的细胞和分子相互作用/反应，以及我们如何 可以更好地利用这些理解，为早期开发高效的纳米技术， 检测、成像和治疗人类疾病。会议将于2016年7月3日至8日在 奥地利施洛斯赫恩斯坦，Lola Eniola-Adefeso教授（密歇根大学）担任会议 主席和Paolo Decuzzi博士（意大利理工学院）担任共同主席。会议将汇集 来自地球仪的生物学家、材料科学家、物理学家、工程师和临床科学家。这 会议将是一个论坛，讨论在该领域的新机遇和挑战， 纳米技术在医学中的应用，并促进科学家之间的协同合作， 不同的背景和专业知识。因此，在医学ECI会议纳米技术适合 国家生物医学成像和生物工程研究所（NIBIB）的使命是“通过 通过整合生物医学技术，引领生物医学技术的发展和加速应用， 物理和工程科学与生命科学相结合，以推进基础研究和医疗保健。” 本次会议的主要议题包括纳米技术的发展（1）细胞研究 粘附、生长和分化;和（2）用于诊断、治疗和组织工程。因此我们 预计这次会议上的科学互动将促进“早期技术的发展， 疾病检测和健康状况评估。

The central objective of this ECI conference on Nanotechnology in Medicine is to provide a platform for global discussion amongst researchers in the field with the overall goal of aiding the mechanistic understanding of cellular and molecular interactions/responses induced by nanotechnologies and how we can better exploit these understandings to generate highly effective nanotechnologies for the early detection, imaging and treatment of human diseases. The conference will be held July 3 – 8, 2016 in Schloss Hernstein, Austria with Prof. Lola Eniola-Adefeso (University of Michigan) serving as conference chair and Dr. Paolo Decuzzi (Italian Institute of Technology) as co-chair. The conference will bring together biologists, materials scientists, physicists, engineers and clinical scientists from across the globe. This conference will represent a forum to discuss new opportunities and challenges in the field of nanotechnology in medicine and to foster the development of synergic collaborations among scientists with diverse backgrounds and expertise. As such, the Nanotechnology in Medicine ECI conference fit the mission of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) “to improve health by leading the development and accelerating the application of biomedical technologies by the integration of the physical and engineering sciences with the life sciences to advance basic research and medical care.” The key topics to be covered in this conference include development of nanotechnology for (1) study of cell adhesion, growth and differentiation; and (2) for diagnostic, therapeutics and tissue engineering. Thus, we anticipate that the scientific interactions at this conference will foster “development of technologies for early disease detection and assessment of health status.